Back to feed
Good News Network
Original article ·
Good News
#hope
Experimental Drug Generates Immune Response Against Pancreatic Cancer in People at High Risk
Researchers at Johns Hopkins report that an experimental drug targeting one of the most common genetic drivers of pancreatic cancer was safe in humans, and generated durable immune responses aimed at preventing the cancer in people at high
“And we know that in all things God works for the good of those who love him, who have been called according to his purpose.”
— Romans 8:28